If you look at the stem cell industry the major problem is that everyone is trying to process on-site. Typically these on-site locations are not laboratories but rather just a side room in a physician's office. With this IRB approval it seems that CRYO can offer their services to physician for studies the right way.
In other words, they just entered a whole new market of providing stem cells to therapeutic locations.
News 
Market Data 
Discover 
AI
